HMT-3522 S1 Cell Line

Product Name	HMT-3522 S1 Cell Line
Cat.No	RWT-743
Size	1*10^6 cells/vial
Description	HMT-3522 S1, also known as HMT-3522/wt, is a subline that has been derived from HMT-3522. The parent line was established from a benign breast tumour of a 48 year old woman and has undergone spontaneous malignant transformation.
Tissue	Breast
Species	Homo sapiens, human
Gender	N/A
Disease	Human Caucasian breast epithelial
Biosafety Level	BSL 1. Runtogen determines the biosafety level of a material based on our risk assessment as guided by the current edition of Biosafety in Microbiological and Biomedical Laboratories (BMBL), U.S. Department of Health and Human Services.
Morphology	Epithelial-like Adherent
Culture Method	DMEM / Ham's F12 (1:1) + 2mM Glutamine + 250ng/ml insulin + 10µg/ml transferrin +10E-8M sodium selenite + 10E-10M 17 beta-estradiol + 0.5µg/ml hydrocortisone + 5µg/ml ovine prolactin + 10ng/ml EGF
Quality Control	HMT-3522 S1 Cell Line is negative for mycoplasma, bacteria, yeast, and fungi.
Shipping	Cryopreserved cells are shipped with dry ice
Storage	Upon arrival, Check all containers for leakage or breakage. Remove the frozen cells from the dry ice packaging and immediately place the cells at a temperature below -130°C, preferably in liquid nitrogen vapor, until ready for use.
Warranty	HMT-3522 S1 Cell Line is warranted for 30 days from the date of shipment, provided that the customer has stored and handled the product according to the information included on the product datasheet, website, and COA.
Disclaimers	Our cell line product is intended for laboratory research use only. It is not intended for any human or animal therapeutic use, any animal or human consumption, or any diagnostic use. Any proposed commercial use is prohibited without a license from Runtogen.

HMT-3522 S1 Cell Line

Online Inquiry

Online Inquiry